Skip to main content
Table of Contents
Print

Can Cannabis CBN or CBG Support Breathing During Sleep? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Cannabis compounds beyond THC and CBD are gaining attention for their potential therapeutic benefits. Specifically, CBN or CBG for sleep apnoea  has been explored for its ability to support breathing and promote restful sleep. These minor cannabinoids may offer alternative options for patients seeking cannabinoid for airway support. 

Current Research 

Early studies suggest that CBN or CBG for sleep apnoea may influence respiratory patterns during sleep. Although clinical data is limited, the potential for minor cannabinoids to support airway function is being actively investigated. 

Mechanism of Action 

CBN or CBG for sleep apnoea interacts with the endocannabinoid system, potentially affecting muscle tone in the upper airway and sleep regulation. 

Clinical Evidence 

Most research on minor cannabinoids for OSA is preclinical, but initial findings indicate possible reductions in apnoea events. 

Usage Considerations 

Patients should consult healthcare providers before using CBN or CBG. Cannabinoid for airway support therapies require careful dosing and monitoring due to limited long-term safety data. 

Accessibility 

Minor cannabinoids are available in various formulations, but quality and concentration vary widely. Clinicians should guide patients to reputable sources. 

While CBN or CBG for sleep apnoea shows promise, evidence remains preliminary. Minor cannabinoids may become part of future cannabinoid for airway support strategies, but current use should be cautious and supervised by medical professionals. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories